Chapter 10 — Case Study 1: DNA Methylation, Epigenetics, and the Single-Carbon Currency of Life
How an $S_N2$ reaction at a methyl carbon controls which of your genes are turned on, decides cellular identity, and sits at the heart of cancer, aging, and inheritance.
1. The reaction
In every cell of your body, billions of times per day, the same $S_N2$ reaction runs: a methyl group transfers from S-adenosylmethionine (SAM) to a substrate, leaving behind S-adenosylhomocysteine (SAH).
The general reaction:
$$\text{SAM} + \text{Nu:} \to \text{SAH} + \text{Nu-CH}_3$$
The nucleophile (Nu) varies with the enzyme — it can be the nitrogen of a DNA base, the oxygen of a histone tail, the nitrogen of an amino acid in a protein, the carboxylate of a fatty acid, or one of several other nucleophilic atoms in the cell. But the chemistry is the same: backside attack at the methyl carbon of SAM, with SAH as the leaving group.
This reaction is the chemical basis of methylation — the most widespread reversible chemical modification in biology. The chemistry is exactly Chapter 10's $S_N2$.
2. The components
SAM (S-adenosylmethionine) is a methyl donor. It consists of: - An adenosine (the nucleoside of adenine + ribose). - A methionine residue connected to the ribose's 5'-position via a sulfonium bond. - The sulfonium center has three substituents: the adenosyl group, the methionine carboxylate-side chain, and the methyl group that will transfer.
The sulfonium is what makes SAM an excellent methylating agent. Sulfonium ions ($R_3S^+$) are about a thousand times more reactive than neutral sulfides, because the positive charge on sulfur makes the adjacent carbon more electrophilic and stabilizes the leaving group (SAH, the neutral sulfide product).
SAH (S-adenosylhomocysteine) is the leaving group. It is the same molecule as SAM minus the methyl group — adenosine + homocysteine, connected via a normal (neutral) sulfide bond. As a leaving group from $S_N2$, SAH leaves cleanly because the sulfonium-to-neutral-sulfide change is highly favorable (similar to a bromide leaving from a $C-Br^+$ in some sense — although the $C$ involved is the methyl, not the sulfur itself).
Nucleophiles that attack SAM include: - The C5 carbon of cytosine (in DNA → leading to 5-methylcytosine, the central epigenetic mark). - The N6 nitrogen of adenine (in some prokaryotes, → N6-methyladenine). - The lysine ε-amine (in histones, the proteins that package DNA). - Various oxygen atoms in tRNA, rRNA, and other nucleic acids. - Nitrogen, oxygen, and carbon atoms in many small-molecule biosynthetic pathways.
Each enzyme that catalyzes an $S_N2$ on SAM is called a methyltransferase.
3. The chemistry
The $S_N2$ at the methyl carbon of SAM has all the characteristic features of Chapter 10:
Geometry: backside attack. The nucleophile approaches the methyl carbon from the side opposite to the sulfonium leaving group. The three hydrogens of the methyl group invert during the reaction, swinging from the SAM side to the product side. (Stereochemistry of the methyl is not chemically relevant — three identical H's — but isotope-labeled experiments using $CD_3$-SAM demonstrate that the methyl carbon does undergo classical inversion at the moment of transfer.)
Kinetics: second order overall — first order in SAM, first order in nucleophile. Enzyme-catalyzed reactions tighten this further by binding both substrates simultaneously in a "ternary complex" that converts essentially irreversibly to product + SAH.
Activation energy: the uncatalyzed reaction has $E_a$ around 30–35 kcal/mol — slow at body temperature without enzyme. The enzyme catalyzes the reaction with $E_a$ around 15 kcal/mol, an acceleration of $\sim 10^{12}$.
Leaving group quality: SAH leaves as a neutral sulfide. The sulfonium-to-sulfide transition has $pK_a$ of the conjugate acid around –5 to –7, making SAH comparable to a chloride or bromide leaving group in quality. This is "good enough" for the reaction to proceed.
4. The biological consequences
DNA methylation has profound consequences for gene regulation:
5-methylcytosine and gene silencing
Most mammalian DNA methylation occurs at CpG dinucleotides — places where a cytosine sits adjacent to a guanine. The cytosine's C5 is methylated to give 5-methylcytosine (5mC).
Methylation patterns are inherited through cell division. When DNA replicates, the daughter strand is methylated at the same CpG positions as the parent — a "maintenance methyltransferase" (DNMT1) recognizes hemimethylated DNA (parent methylated, daughter not) and methylates the daughter to match. Different methylation patterns thus persist through the body — a liver cell maintains liver-cell methylation through millions of divisions, while a neuron maintains neuron-cell methylation. This is epigenetic inheritance — heritable information stored not in the DNA sequence but in chemical modifications layered on top.
Functionally, DNA methylation usually represses gene expression. CpG-methylated promoters bind methyl-CpG-binding proteins (MeCP2 and others), which recruit histone deacetylases and other repressive machinery. The genes on those promoters become silent.
This is the molecular basis of the rule "different cell types use different subsets of the same genome" — every cell in your body has the same DNA, but each cell type uses a different subset of genes. That subset is largely defined by the methylation pattern.
Cancer and aberrant methylation
Cancer cells often have dramatically dysregulated DNA methylation: - Hypomethylation of oncogenes: many tumors lose methylation at oncogene-promoter CpGs, allowing the oncogene to be inappropriately expressed. - Hypermethylation of tumor-suppressor genes: tumors gain methylation at tumor-suppressor promoters, silencing genes that would otherwise stop the cancer. - Global hypomethylation: many tumors show decreased overall methylation, leading to genomic instability.
Several FDA-approved cancer drugs target DNA methylation: - 5-azacytidine (Vidaza) and decitabine (Dacogen): nucleoside analogs that get incorporated into DNA, where they block DNMT activity by trapping the enzyme covalently. Used in myelodysplastic syndromes and some leukemias. - These drugs work by interfering with the $S_N2$ reaction discussed in this chapter — specifically by binding the methyltransferase active site so that the methyl-transfer step can't occur.
Aging
Methylation patterns drift slowly with age. Specific CpG sites change methylation in a way correlated with chronological age, allowing the construction of "epigenetic clocks" — methylation profiles that predict biological age.
The Horvath clock (2013) and similar tools predict age within ±3 years from 350 CpG methylation values. This is now used in research on lifespan-extending interventions and as a biomarker for various diseases.
What drives the age-related changes is partly biological (DNMT regulation, demethylase activity) and partly entropic — even small per-cycle deviations in methylation maintenance accumulate over decades.
Histone methylation
Beyond DNA, the histone proteins that package DNA into chromatin are also methylated by SAM-dependent enzymes. Specific lysine and arginine residues on histone tails get methylated: - H3K4me3 (histone 3, lysine 4, trimethyl): mark of active transcription. - H3K9me3: mark of constitutive heterochromatin (silenced genes). - H3K27me3: mark of facultative heterochromatin. - And more.
The writers (methyltransferases), erasers (demethylases), and readers (methyl-binding proteins) of histone marks define the histone code — the second level of the epigenetic regulatory system.
Each writer enzyme catalyzes an $S_N2$ on SAM at a specific position of a specific histone residue. The chemistry is Chapter 10. The biology is gene regulation at scale.
5. The single-carbon currency of life
SAM is one of about a dozen "metabolic currencies" — small molecules that ferry chemical energy or chemical groups around the cell. ATP carries phosphates; NADH carries hydrides; coenzyme A carries acyl groups. SAM carries methyl groups.
The specific role of methyl-group transfer in biology is enormous. Some examples beyond DNA and histones:
- Phosphatidylcholine biosynthesis: phosphatidylethanolamine is methylated three times by SAM to give phosphatidylcholine (a major membrane phospholipid).
- Catechol-O-methyltransferase (COMT): methylates catechols (including dopamine, epinephrine, norepinephrine) for inactivation/degradation. Polymorphisms in COMT are linked to behavioral traits.
- Histidine methylation in cytochrome c: a specific histidine is methylated post-translationally; this small modification affects electron-transfer properties.
- Polyamine biosynthesis: spermidine and spermine production involves SAM-derived methyl-derived units.
- Plant alkaloid biosynthesis: morphine, nicotine, caffeine, and many other alkaloids include methyl groups derived from SAM.
A typical human cell uses billions of SAM molecules per day. SAM is regenerated from SAH by removal of the homocysteine and re-methylation (a multi-step pathway involving folate cycles). The regeneration costs about 1 ATP per methyl transfer, plus the methyl-group source from the C1-folate pool.
6. The lesson for Chapter 10
Methylation by SAM is a textbook $S_N2$ — backside attack on a methyl carbon, sulfonium leaving group, second-order kinetics. It is the same chemistry as $CH_3I + HO^-$ in your test tube, scaled to billions of events per cell per day.
What changes between the lab reaction and the biological reaction is not the chemistry but the scale and the catalysis. Enzymes accelerate $S_N2$ at a level no synthetic chemist can match — by $10^{12}$ — through: 1. Binding both substrates in proper orientation (proximity). 2. Stabilizing the developing partial charges in the TS (electrostatic catalysis). 3. Pre-organizing the nucleophile (general acid-base chemistry).
Chapter 10's mechanisms underlie every line of the genome's regulation.
When you draw an $S_N2$ arrow on the test tube, you are drawing the same arrow that runs in your liver right now, methylating SAM into SAH so a histone tail can be re-marked, so a gene can be turned off.
Further reading: - Cheng, X., and Blumenthal, R. M. (eds.) (2010). S-Adenosylmethionine-Dependent Methyltransferases: Structures and Functions. World Scientific. - Smith, Z. D., and Meissner, A. (2013). DNA methylation: roles in mammalian development. Nat. Rev. Genet. 14, 204. - Horvath, S. (2013). DNA methylation age of human tissues and cell types. Genome Biol. 14, R115. - Issa, J.-P. J. (2007). DNA methylation as a therapeutic target in cancer. Clin. Cancer Res. 13, 1634. - Allis, C. D., and Jenuwein, T. (2016). The molecular hallmarks of epigenetic control. Nat. Rev. Genet. 17, 487.